ICYMI: The 14 drugs most likely to top global pharma sales in 2015 and 2020

December 19, 2014 8:04 PM

17 0

Earlier this week, BioPharma Dive reported on the 11 biggest expected drug launches to watch out for in 2015. BMS's anti-PD-1 drug Opdivo and PCSK9 cholesterol inhibitors from Sanofi and Amgen are expected to comprise some of the biggest launches in the industry and to eventually reach blockbuster status.

But there's plenty of already-approved drugs on the market right now that will likely make 2015 yet another massive year for pharma sales worldwide, according to equity analysts' projections aggregated in a big new report (gated) from EvaluatePharma. Old reliables like AbbVie's Humira and red-hot ne...

Read more

To category page